<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75374</article-id><article-id pub-id-type="doi">10.7554/eLife.75374</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-260042"><name><surname>Morales Berstein</surname><given-names>Fernanda</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8237-2021</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261585"><name><surname>McCartney</surname><given-names>Daniel L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-215458"><name><surname>Lu</surname><given-names>Ake T</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-261584"><name><surname>Tsilidis</surname><given-names>Konstantinos K</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261590"><name><surname>Bouras</surname><given-names>Emmanouil</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87280"><name><surname>Haycock</surname><given-names>Philip C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5001-3350</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261586"><name><surname>Burrows</surname><given-names>Kimberley</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261589"><name><surname>Phipps</surname><given-names>Amanda I</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261587"><name><surname>Buchanan</surname><given-names>Daniel D</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261588"><name><surname>Cheng</surname><given-names>Iona</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>The PRACTICAL Consortium</collab></contrib><contrib contrib-type="author" id="author-87278"><name><surname>Martin</surname><given-names>Richard M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7992-7719</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-11"/><xref ref-type="other" rid="par-12"/><xref ref-type="other" rid="par-13"/><xref ref-type="other" rid="par-14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49227"><name><surname>Davey Smith</surname><given-names>George</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1407-8314</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87277"><name><surname>Relton</surname><given-names>Caroline L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2052-4840</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35782"><name><surname>Horvath</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-158517"><name><surname>Marioni</surname><given-names>Riccardo E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4430-4260</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-38000"><name><surname>Richardson</surname><given-names>Tom G</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7918-2040</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-261583"><name><surname>Richmond</surname><given-names>Rebecca C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">MRC Integrative Epidemiology Unit</institution>, <institution>University of Bristol</institution>, <addr-line><named-content content-type="city">Bristol</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Centre for Genomic and Experimental Medicine</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Department of Human Genetics</institution>, <institution>University of California, Los Angeles</institution>, <addr-line><named-content content-type="city">Los Angeles</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Epidemiology and Biostatistics</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Department of Hygiene and Epidemiology</institution>, <institution>University of Ioannina</institution>, <addr-line><named-content content-type="city">Ioannina</named-content></addr-line>, <country>Greece</country></aff><aff id="aff6"><institution content-type="dept">Public Health Sciences Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Clinical Pathology</institution>, <institution>University of Melbourne</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff8"><institution>Cancer Prevention Institute of California</institution>, <addr-line><named-content content-type="city">Fremont</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Population Health Sciences</institution>, <institution>University of Bristol</institution>, <addr-line><named-content content-type="city">Bristol</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-242743"><name><surname>Rovers</surname><given-names>Maroeska M</given-names></name><role>Reviewing editor</role><aff><institution>Radboud University Nijmegen</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>dy20206@bristol.ac.uk</email> (FM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>29</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e75374</elocation-id><history><date date-type="received"><day>08</day><month>11</month><year>2021</year></date><date date-type="accepted"><day>10</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Morales Berstein et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Morales Berstein et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75374-v1.pdf"/><abstract><p><bold>Background:</bold> Epigenetic clocks have been associated with cancer risk in several observational studies. Nevertheless, it is unclear whether they play a causal role in cancer risk or if they act as a non-causal biomarker.</p><p><bold>Methods:</bold> We conducted a two-sample Mendelian randomization (MR) study to examine the genetically predicted effects of epigenetic age acceleration as measured by HannumAge (9 single-nucleotide polymorphisms (SNPs)), Horvath Intrinsic Age (24 SNPs), PhenoAge (11 SNPs) and GrimAge (4 SNPs) on multiple cancers (i.e., breast, prostate, colorectal, ovarian and lung cancer). We obtained genome-wide association data for biological ageing from a meta-analysis (N=34,710), and for cancer from the UK Biobank (N cases=2,671-13,879; N controls=173,493-372,016), FinnGen (N cases=719-8,401; N controls=74,685-174,006) and several international cancer genetic consortia (N cases=11,348-122,977; N controls=15,861-105,974). Main analyses were performed using multiplicative random effects inverse variance weighted (IVW) MR. Individual study estimates were pooled using fixed effect meta-analysis. Sensitivity analyses included MR-Egger, weighted median, weighted mode and Causal Analysis using Summary Effect Estimates (CAUSE) methods, which are robust to some of the assumptions of the IVW approach.</p><p><bold>Results:</bold> Meta-analysed IVW MR findings suggested that higher GrimAge acceleration increased the risk of colorectal cancer (OR=1.12 per year increase in GrimAge acceleration, 95%CI 1.04-1.20, <italic>p</italic>=0.002). The direction of the genetically predicted effects was consistent across main and sensitivity MR analyses. Among subtypes, the genetically predicted effect of GrimAge acceleration was greater for colon cancer (IVW OR=1.15, 95%CI 1.09-1.21, <italic>p</italic>=0.006), than rectal cancer (IVW OR=1.05, 95%CI 0.97-1.13, <italic>p</italic>=0.24). Results were less consistent for associations between other epigenetic clocks and cancers.</p><p><bold>Conclusions:</bold> GrimAge acceleration may increase the risk of colorectal cancer. Findings for other clocks and cancers were inconsistent. Further work is required to investigate the potential mechanisms underlying the results.</p><p><bold>Funding:</bold> FMB was supported by a Wellcome Trust PhD studentship in Molecular, Genetic and Lifecourse Epidemiology (224982/Z/22/Z which is part of grant 218495/Z/19/Z). KKT was supported by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme) and by the Hellenic Republic's Operational Programme 'Competitiveness, Entrepreneurship &amp; Innovation' (OÎ Î£ 5047228). PH was supported by Cancer Research UK (C18281/A29019). RMM was supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). RMM is a National Institute for Health Research Senior Investigator (NIHR202411). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. GDS and CLR were supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/5) and by a Cancer Research UK (C18281/A29019) programme grant (the Integrative Cancer Epidemiology Programme). REM was supported by an Alzheimer's Society project grant (AS-PG-19b-010) and NIH grant (U01 AG-18-018, PI: Steve Horvath). RCR is a de Pass Vice Chancellor's Research Fellow at the University of Bristol.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>224982/Z/22/Z</award-id><principal-award-recipient><name><surname>Morales Berstein</surname><given-names>Fernanda</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/1 and MC_UU_00011/5</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A29019</award-id><principal-award-recipient><name><surname>Relton</surname><given-names>Caroline L</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A29019</award-id><principal-award-recipient><name><surname>Davey Smith</surname><given-names>George</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000320</institution-id><institution>Alzheimer's Society</institution></institution-wrap></funding-source><award-id>AS-PG-19b-010</award-id><principal-award-recipient><name><surname>Marioni</surname><given-names>Riccardo E</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01 AG-18-018,PI: Steve Horvath</award-id><principal-award-recipient><name><surname>Marioni</surname><given-names>Riccardo E</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>de Pass Vice Chancellor's Research Fellow at the University of Bristol</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Richmond</surname><given-names>Rebecca C</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A29019</award-id><principal-award-recipient><name><surname>Tsilidis</surname><given-names>Konstantinos K</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Hellenic Republic's Operational Programme 'Competitiveness, Entrepreneurship &amp; Innovation'</institution></institution-wrap></funding-source><award-id>O&amp;#x03A0;&amp;#x03A3; 5047228</award-id><principal-award-recipient><name><surname>Tsilidis</surname><given-names>Konstantinos K</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A29019</award-id><principal-award-recipient><name><surname>Haycock</surname><given-names>Philip C</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C18281/A29019</award-id><principal-award-recipient><name><surname>Martin</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="par-12"><funding-source><institution-wrap><institution>NIHR Biomedical Research Centre at University Hospitals Bristol</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Martin</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="par-13"><funding-source><institution-wrap><institution>Weston NHS Foundation Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Martin</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="par-14"><funding-source><institution-wrap><institution>NIHR Senior Investigator</institution></institution-wrap></funding-source><award-id>NIHR202411</award-id><principal-award-recipient><name><surname>Martin</surname><given-names>Richard M</given-names></name></principal-award-recipient></award-group><award-group id="par-15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00011/1 and MC_UU_00011/5</award-id><principal-award-recipient><name><surname>Relton</surname><given-names>Caroline L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Ake T Lu, declares that UC Regents filed the patent DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY&quot; (International Application Number PCT/US2019/055444; in pending status) and that the Epigenetic Clock Development Foundation and Foxo Labs hold licenses.&quot;.</p></fn><fn fn-type="conflict" id="conf3"><p>Steve Horvath, declares that UC Regents filed the patent DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY&quot; (International Application Number PCT/US2019/055444; in pending status) and that the Epigenetic Clock Development Foundation and Foxo Labs hold licenses. SH receives consulting fees from the Epigenetic Clock Development Foundation and royalties for patents involving epigenetic clocks.&quot;.</p></fn><fn fn-type="conflict" id="conf4"><p>Riccardo E Marioni, has received a speaker fee from Illumina and is an advisor to the Epigenetic Clock Development Foundation..</p></fn><fn fn-type="conflict" id="conf5"><p>Tom G Richardson, is employed part time by Novo Nordisk outside of this work..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This research did not require ethical approval as it used secondary, genome-wide association data from studies that obtained informed consent from all participants and ethical approval from review boards and/or ethics committees.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Summary statistics for epigenetic age acceleration measures of HannumAge, Intrinsic HorvathAge, PhenoAge and GrimAge were downloaded from: https://datashare.ed.ac.uk/handle/10283/3645.  Summary statistics for international cancer genetic consortiums were obtained from their respective data repositories. Colorectal cancer data were obtained following the submission of a written request to the GECCO committee, which may be contacted by email at kafdem@fredhutch.org/upeters@fredhutch.org. Breast, ovarian, prostate and lung cancer data were accessed via MR-Base (http://app.mrbase.org/), which holds complete GWAS summary data from BCAC, OCAC, PRACTICAL and ILCCO. Breast cancer subtype data were obtained from BCAC and can be downloaded from: http://bcac.ccge.medschl.cam.ac.uk/bcacdata/oncoarray/oncoarray-and-combined-summary-result/gwas-summary-associations-breast-cancer-risk-2020/. Data on breast and ovarian cancer in BRCA1 and BRCA2 carriers were obtained from CIMBA and can be downloaded from: http://cimba.ccge.medschl.cam.ac.uk/oncoarray-complete-summary-results/. Prostate cancer subtype data are not publicly available through MR-Base but can be accessed upon request. These data are managed by the PRACTICAL committee, which may be contacted by email at practical@icr.ac.uk. FinnGen data is publicly available and can be accessed here: https://www.finngen.fi/en/access_results. UK Biobank data can be accessed through the MR-Base platform. Parental history of cancer data were obtained from the UK Biobank study under application #15825 and can be accessed via an approved application to the UK Biobank (https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access). GWAS data for negative control outcomes and potential confounders were obtained via the MR-Base platform (GWAS IDs for negative control outcomes: &quot;ukb-b-19560&quot;, &quot;ukb-b-533&quot;; GWAS IDs for confounders: &quot;ukb-b-10831&quot;, &quot;ukb-b-13702&quot;, &quot;ukb-b-6134&quot;, &quot;ieu-a-1239&quot;, &quot;ukb-b-5779&quot;, &quot;ieu-a-835&quot;, &quot;ieu-a-61&quot;). GWAS data for measured telomere length used in bidirectional MR analyses were also obtained via the MR-Base platform (GWAS ID: &quot;ieu-b-4879&quot;).</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>McCartney DL</collab><collab>Min JL</collab><collab>Richmond RC</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>European-ancestries meta-analysis summary statistics: Hannum (645.4Mb)</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7488/ds/2834">https://doi.org/10.7488/ds/2834</ext-link><comment>Edinburgh DataShare doi:10.7488/ds/2834</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>McCartney DL</collab><collab>Min JL</collab><collab>Richmond RC</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>European-ancestries meta-analysis summary statistics: IEAA (645.7Mb)</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7488/ds/2834">https://doi.org/10.7488/ds/2834</ext-link><comment>Edinburgh DataShare doi:10.7488/ds/2834</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>McCartney DL</collab><collab>Min JL</collab><collab>Richmond RC</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>European-ancestries meta-analysis summary statistics: GrimAge (645.7Mb)</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7488/ds/2834">https://doi.org/10.7488/ds/2834</ext-link><comment>Edinburgh DataShare doi:10.7488/ds/2834</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>McCartney DL</collab><collab>Min JL</collab><collab>Richmond RC</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>European-ancestries meta-analysis summary statistics: PhenoAge (645.7Mb)</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7488/ds/2834">https://doi.org/10.7488/ds/2834</ext-link><comment>Edinburgh DataShare doi:10.7488/ds/2834</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1120/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1120/</ext-link><comment>IEU OpenGWAS, ieu-a-1120</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Schumacher</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Prostate cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-b-85/">https://gwas.mrcieu.ac.uk/datasets/ieu-b-85/</ext-link><comment>IEU OpenGWAS, ieu-b-85</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Michailidou K</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1126/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1126/</ext-link><comment>IEU OpenGWAS, ieu-a-1126</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Y</collab><collab>et al</collab></person-group><year iso-8601-date="2014">2014</year><source>Lung cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-966/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-966/</ext-link><comment>IEU OpenGWAS, ieu-a-966</comment></element-citation><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Y</collab><collab>et al</collab></person-group><year iso-8601-date="2014">2014</year><source>Lung adenocarcinoma</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-965/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-965/</ext-link><comment>IEU OpenGWAS, ieu-a-965</comment></element-citation><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Wang Y</collab><collab>et al</collab></person-group><year iso-8601-date="2014">2014</year><source>Squamous cell lung cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-967/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-967/</ext-link><comment>IEU OpenGWAS, ieu-a-967</comment></element-citation><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>High grade serous ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1121/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1121/</ext-link><comment>IEU OpenGWAS, ieu-a-1121</comment></element-citation><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Low grade serous ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1122/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1122/</ext-link><comment>IEU OpenGWAS, ieu-a-1122</comment></element-citation><element-citation id="dataset13" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Invasive mucinous ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1123/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1123/</ext-link><comment>IEU OpenGWAS, ieu-a-1123</comment></element-citation><element-citation id="dataset14" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Clear cell ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1124/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1124/</ext-link><comment>IEU OpenGWAS, ieu-a-1124</comment></element-citation><element-citation id="dataset15" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Phelan</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>Endometrioid ovarian cancer</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1125/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1125/</ext-link><comment>IEU OpenGWAS, ieu-a-1125</comment></element-citation><element-citation id="dataset16" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Michailidou K</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>ER+ Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1127/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1127/</ext-link><comment>IEU OpenGWAS, ieu-a-1127</comment></element-citation><element-citation id="dataset17" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Michailidou K</collab><collab>et al</collab></person-group><year iso-8601-date="2017">2017</year><source>ER- Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis)</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1128/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1128/</ext-link><comment>IEU OpenGWAS, ieu-a-1128</comment></element-citation><element-citation id="dataset18" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>FinnGen consortium</collab></person-group><year iso-8601-date="2021">2021</year><source>Malignant neoplasm of breast (all cancers excluded)</source><ext-link ext-link-type="uri" xlink:href="https://www.finngen.fi/en/access_results">https://www.finngen.fi/en/access_results</ext-link><comment>FinnGen public data r5, finngen_R5_C3_BREAST_EXALLC.gz</comment></element-citation><element-citation id="dataset19" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>FinnGen consortium</collab></person-group><year iso-8601-date="2021">2021</year><source>Malignant neoplasm of bronchus and lung (all cancers excluded)</source><ext-link ext-link-type="uri" xlink:href="https://www.finngen.fi/en/access_results">https://www.finngen.fi/en/access_results</ext-link><comment>FinnGen public data r5, finngen_R5_C3_BRONCHUS_LUNG_EXALLC.gz</comment></element-citation><element-citation id="dataset20" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>FinnGen consortium</collab></person-group><year iso-8601-date="2021">2021</year><source>Colorectal cancer (all cancers excluded)</source><ext-link ext-link-type="uri" xlink:href="https://www.finngen.fi/en/access_results">https://www.finngen.fi/en/access_results</ext-link><comment>FinnGen public data r5, finngen_R5_C3_COLORECTAL_EXALLC.gz</comment></element-citation><element-citation id="dataset21" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>FinnGen consortium</collab></person-group><year iso-8601-date="2021">2021</year><source>Malignant neoplasm of ovary (all cancers excluded)</source><ext-link ext-link-type="uri" xlink:href="https://www.finngen.fi/en/access_results">https://www.finngen.fi/en/access_results</ext-link><comment>FinnGen public data r5, finngen_R5_C3_OVARY_EXALLC.gz</comment></element-citation><element-citation id="dataset22" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>FinnGen consortium</collab></person-group><year iso-8601-date="2021">2021</year><source>Malignant neoplasm of prostate (all cancers excluded)</source><ext-link ext-link-type="uri" xlink:href="https://www.finngen.fi/en/access_results">https://www.finngen.fi/en/access_results</ext-link><comment>FinnGen public data r5, finngen_R5_C3_PROSTATE_EXALLC.gz</comment></element-citation><element-citation id="dataset23" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Codd</collab><collab>et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Telomere length</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-b-4879/">https://gwas.mrcieu.ac.uk/datasets/ieu-b-4879/</ext-link><comment>IEU OpenGWAS, ieu-b-4879</comment></element-citation><element-citation id="dataset24" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Skin colour</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-19560/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-19560/</ext-link><comment>IEU OpenGWAS, ukb-b-19560</comment></element-citation><element-citation id="dataset25" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Ease of skin tanning</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-533/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-533/</ext-link><comment>IEU OpenGWAS, ukb-b-533</comment></element-citation><element-citation id="dataset26" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Pack years of smoking</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-10831/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-10831/</ext-link><comment>IEU OpenGWAS, ukb-b-10831</comment></element-citation><element-citation id="dataset27" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Time spent doing vigorous physical activity</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-13702/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-13702/</ext-link><comment>IEU OpenGWAS, ukb-b-13702</comment></element-citation><element-citation id="dataset28" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Age completed full time education</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-6134/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-6134/</ext-link><comment>IEU OpenGWAS, ukb-b-6134</comment></element-citation><element-citation id="dataset29" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Lee</collab><collab>et al</collab></person-group><year iso-8601-date="2018">2018</year><source>Years of schooling</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-1239/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-1239/</ext-link><comment>IEU OpenGWAS, ieu-a-1239</comment></element-citation><element-citation id="dataset30" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ben Elsworth</collab></person-group><year iso-8601-date="2018">2018</year><source>Alcohol intake frequency</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ukb-b-5779/">https://gwas.mrcieu.ac.uk/datasets/ukb-b-5779/</ext-link><comment>IEU OpenGWAS, ukb-b-5779</comment></element-citation><element-citation id="dataset31" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Locke</collab><collab>et al</collab></person-group><year iso-8601-date="2015">2015</year><source>Body mass index</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-835/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-835/</ext-link><comment>IEU OpenGWAS, ieu-a-835</comment></element-citation><element-citation id="dataset32" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Shungin</collab><collab>et al</collab></person-group><year iso-8601-date="2015">2015</year><source>Waist circumference</source><ext-link ext-link-type="uri" xlink:href="https://gwas.mrcieu.ac.uk/datasets/ieu-a-61/">https://gwas.mrcieu.ac.uk/datasets/ieu-a-61/</ext-link><comment>IEU OpenGWAS, ieu-a-61</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-75374-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>